ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
elari
|
232 |
50K |
3 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
50K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
elari
|
66 |
17K |
6 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
17K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
what odds of house deposit
|
|
elari
|
14 |
3.5K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
14
|
3.5K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
what odds of house deposit
|
|
elari
|
14 |
3.5K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
14
|
3.5K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
elari
|
196 |
36K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
4
|
|
ASX - By Stock
|
PAA |
$1 party
|
|
elari
|
3 |
1.1K |
10 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
3
|
1.1K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
elari
|
114 |
32K |
21 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
114
|
32K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
elari
|
282 |
73K |
7 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
282
|
73K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
elari
|
430 |
106K |
17 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
430
|
106K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
elari
|
430 |
106K |
8 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
430
|
106K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
elari
|
355 |
67K |
2 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
355
|
67K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results of Annual General Meeting
|
|
elari
|
29 |
7.0K |
6 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
29
|
7.0K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Full takeover versus multiple deals?
|
|
elari
|
76 |
13K |
5 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
76
|
13K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Full takeover versus multiple deals?
|
|
elari
|
76 |
13K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
76
|
13K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at Emerging ASX Gems Conference
|
|
elari
|
82 |
17K |
4 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
82
|
17K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
elari
|
83 |
15K |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
83
|
15K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
elari
|
83 |
15K |
6 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
83
|
15K
|
6
|
|
ASX - By Stock
|
KGN |
Shonky award
|
|
elari
|
25 |
6.5K |
5 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
25
|
6.5K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Resignation of Janet West AM
|
|
elari
|
24 |
8.4K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
24
|
8.4K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
elari
|
83 |
15K |
5 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
83
|
15K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
elari
|
83 |
15K |
4 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
83
|
15K
|
4
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
elari
|
816 |
341K |
2 |
18/10/23 |
18/10/23 |
Charts
|
816
|
341K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Options Offer to Existing Listed Option Holders
|
|
elari
|
79 |
16K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
79
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
elari
|
125 |
24K |
7 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
125
|
24K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PHARMAUST 2023 AGM.
|
|
elari
|
15 |
3.1K |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
15
|
3.1K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
elari
|
106 |
21K |
4 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
106
|
21K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
elari
|
106 |
21K |
7 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
106
|
21K
|
7
|
|
ASX - By Stock
|
PAA |
$1 party
|
|
elari
|
21 |
4.6K |
4 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
21
|
4.6K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
FDA....major concerns....Brainstorm ALS therapy
|
|
elari
|
10 |
2.5K |
2 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
10
|
2.5K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
elari
|
218 |
50K |
4 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
218
|
50K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4E & Full Year Statutory Accounts
|
|
elari
|
12 |
3.2K |
8 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
12
|
3.2K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
August , September , OPTOBER ,PAA
|
|
elari
|
144 |
29K |
2 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
144
|
29K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Who wants a Zoom Meeting with Management
|
|
elari
|
28 |
4.9K |
4 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
28
|
4.9K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
elari
|
380 |
83K |
3 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
380
|
83K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
elari
|
218 |
50K |
4 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
218
|
50K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
elari
|
78 |
20K |
8 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
78
|
20K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
elari
|
140 |
31K |
4 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
140
|
31K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
elari
|
396 |
82K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
396
|
82K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
elari
|
396 |
82K |
6 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
396
|
82K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Progress update on Phase 1/2 MND interim analysis
|
|
elari
|
65 |
16K |
8 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
65
|
16K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
elari
|
56 |
14K |
2 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
56
|
14K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Cancer Trial Update
|
|
elari
|
220 |
42K |
8 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
220
|
42K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient of Cohort 2 Dosed in MND Trial
|
|
elari
|
79 |
18K |
2 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
79
|
18K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient of Cohort 2 Dosed in MND Trial
|
|
elari
|
79 |
18K |
5 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
79
|
18K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Option Holders as at 29/12/2020 with only one variation.variations.
|
|
elari
|
64 |
17K |
3 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
64
|
17K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
elari
|
97 |
21K |
5 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
97
|
21K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
elari
|
97 |
21K |
3 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
97
|
21K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Canine Trial Update clarification
|
|
elari
|
97 |
21K |
5 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
97
|
21K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Top Fifty PAA Share Holders as at 30 November 2022
|
|
elari
|
8 |
2.3K |
1 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
RGL |
Re:
Ann: Trading Halt
|
|
elari
|
17 |
6.9K |
0 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
17
|
6.9K
|
0
|
|